Evidence map›Paper›PMID 26784246›Full record

ArticleMetabolites2016

Development of an Optimized Protocol for NMR Metabolomics Studies of Human Colon Cancer Cell Lines and First Insight from Testing of the Protocol Using DNA G-Quadruplex Ligands as Novel Anti-Cancer Drugs.

Ilaria Lauri, Francesco Savorani, Nunzia Iaccarino, Pasquale Zizza, Luigi Michele Pavone, Ettore Novellino, Søren Balling Engelsen, Antonio Randazzo

Abstract read
In one paragraph

Article in Metabolites, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ilaria LauriDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. ilaria.lauri@unina.it.
Francesco SavoraniSpectroscopy & Chemometrics, Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark. frsa@food.ku.dk.
Nunzia IaccarinoDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. nunzia.iaccarino@unina.it.
Pasquale ZizzaExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, 00158 Rome, Italy. zizza@ifo.it.
Luigi Michele PavoneDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", via S. Pansini 5, 80131 Naples, Italy. luigimichele.pavone@unina.it.
Ettore NovellinoDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. ettore.novellino@unina.it.
Søren Balling EngelsenSpectroscopy & Chemometrics, Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark. se@food.ku.dk.
Antonio RandazzoDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. antonio.randazzo@unina.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of cell lines by nuclear magnetic resonance (NMR) spectroscopy metabolomics represents a powerful tool to understand how the local metabolism and biochemical pathways are influenced by external or internal stimuli. In particular, the use of adherent mammalian cells is emerging in the metabolomics field in order to understand the molecular mechanism of disease progression or, for example, the cellular response to drug treatments. Hereto metabolomics investigations for this kind of cells have generally been limited to mass spectrometry studies. This study proposes an optimized protocol for the analysis of the endo-metabolome of human colon cancer cells (HCT116) by NMR. The protocol includes experimental conditions such as washing, quenching and extraction. In order to test the proposed protocol, it was applied to an exploratory study of cancer cells with and without treatment by anti-cancer drugs, such as DNA G-quadruplex binders and Adriamycin (a traditional anti-cancer drug). The exploratory NMR metabolomics analysis resulted in NMR assignment of all endo-metabolites that could be detected and provided preliminary insights about the biological behavior of the drugs tested.

Indexed as

cell metabolomicscolon cancerG-quadruplex ligandsMultivariate statistical analysisNMR spectroscopy

Identifiers

PMID26784246
PMCPMC4812333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.